COMP <GO>
XNDU vs ZEPP // NET PROFIT MARGIN
Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (NASDAQ) VS. Zepp Health Corporation each representing sixteen (Class A) (NYSE) • 15-METRIC TALLY: XNDU 2
— ZEPP 0
■ METRIC PARITY
XNDU — Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares
ROARABLE D • RQD 49/100
LAST: $3.11 (-3.11%) • MKT CAP: $946.1M
net-margins
—
LAST: $2.25 (-3.85%) • MKT CAP: $33.0M
net-margins
-15.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XNDU VS. ZEPP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XNDU | ZEPP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 38.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -14.70% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -11.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | -15.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 41.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.33 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 5/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.3 | 11.4 | +18.89 | XNDU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $946.1M | $33.0M | $913.1M | XNDU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XNDU REV | ZEPP REV | XNDU GROSS % | ZEPP GROSS % | XNDU FCF | ZEPP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $258.9M | — | 38.3% | — | -$26.2M |
| FY 2024 | — | $182.6M | — | 38.5% | — | -$25.8M |
| FY 2023 | — | $352.9M | — | — | — | $42.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XNDU // BETA —
ZEPP // BETA —